Back
ACADIA Pharmaceuticals Vs. Supernus Pharmaceuticals Industry Stock Comparison
Sell
28
ACAD
ACADIA Pharmaceuticals
Last Price:
16.53
Seasonality Move:
0.51%
Sell
27
SUPN
Supernus Pharmaceuticals
Last Price:
31.81
Seasonality Move:
-10.48%
Sell
28
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $16.53. The Score for ACAD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $31.83. The Score for SUPN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $16.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $31.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 54.11 | Buy |
Chaikin Money Flow: | 1056502 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.71 - 16.39) | Buy |
Bollinger Bands (100): | (15.03 - 17.49) | Buy |
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 43.66 | Sell |
Chaikin Money Flow: | -233670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.09 - 35.05) | Sell |
Bollinger Bands (100): | (27.02 - 32.74) | Buy |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.24 | Buy |
20-day SMA: | 16.15 | Buy |
50-day SMA: | 16.84 | Sell |
200-day SMA: | 19.95 | Sell |
8-day EMA: | 16.29 | Buy |
20-day EMA: | 16.23 | Buy |
50-day EMA: | 16.42 | Buy |
200-day EMA: | 18.67 | Sell |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.51 | Buy |
20-day SMA: | 33.35 | Sell |
50-day SMA: | 31.99 | Sell |
200-day SMA: | 29.79 | Buy |
8-day EMA: | 32.03 | Sell |
20-day EMA: | 32.58 | Sell |
50-day EMA: | 31.9 | Sell |
200-day EMA: | 30.36 | Buy |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.88 per share, and an increase next year of $0.31 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
ACADIA Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Supernus Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |